Cargando…
Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers
BACKGROUND: We examined the effect of the oral SIRT1 activator SRT2104 on cardiovascular function in otherwise healthy cigarette smokers. METHODS AND RESULTS: Twenty‐four otherwise healthy cigarette smokers participated in a randomized double‐blind, placebo‐controlled crossover trial and received 28...
Autores principales: | Venkatasubramanian, Sowmya, Noh, Radzi Mohd, Daga, Shruti, Langrish, Jeremy P., Joshi, Nikhil V., Mills, Nicholas L., Hoffmann, Ethan, Jacobson, Eric W., Vlasuk, George P., Waterhouse, Brian R., Lang, Ninian N., Newby, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3698759/ https://www.ncbi.nlm.nih.gov/pubmed/23770971 http://dx.doi.org/10.1161/JAHA.113.000042 |
Ejemplares similares
-
Effects of the small molecule SIRT1 activator, SRT2104 on arterial stiffness in otherwise healthy cigarette smokers and subjects with type 2 diabetes mellitus
por: Venkatasubramanian, Sowmya, et al.
Publicado: (2016) -
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus
por: Noh, Radzi M, et al.
Publicado: (2017) -
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis
por: Krueger, James G., et al.
Publicado: (2015) -
Sirtuin 1 activator SRT2104 protects Huntington's disease mice
por: Jiang, Mali, et al.
Publicado: (2014) -
A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers
por: Libri, Vincenzo, et al.
Publicado: (2012)